A while ago, I was reviewing which stocks with future potential were worth considering for that 2024 period, and honestly, the outlook looked quite interesting. The markets were in an upward phase, inflation was decreasing, and all signs pointed to possible interest rate cuts.

The first thing that caught my attention was Alphabet. The company was experiencing a 58% year-over-year growth at that time, and its focus on artificial intelligence with Gemini seemed serious. What I liked was that its P/E ratio was at 29, significantly lower than the sector average which exceeded 35. That suggested room for movement. With over $77 billion in free cash flow, the company had the financial muscle to innovate without issues.

Then there was Nvidia, which honestly was impossible to ignore. It controlled nearly 90% of the AI chip market at that time. The shares had already risen 239% in 2023 and continued to have momentum. Technical analysis showed sustained movement, with the stock moving beyond its moving averages. Anyone following the artificial intelligence scene knew Nvidia was the winning horse.

In the pharmaceutical sector, Novo Nordisk seemed particularly interesting to me. The company was leading the anti-obesity medication market, a sector projected to reach $44 billion by 2030. With Ozempic as its flagship product and a 47% profit growth during the first nine months of 2023, the company was well-positioned to capitalize on this trend.

Berkshire Hathaway represented the most conservative option. With Warren Buffett at the helm and $157 billion in cash, the company offered stability. Its beta of 0.64 meant it experienced less fluctuation than the overall market, making it attractive for those seeking peace of mind.

Broadcom was the wild card. It had grown 108% in 2023, and the acquisition of VMware allowed it to diversify beyond semiconductors. They projected a 40% revenue growth for 2024, positioning it as an interesting bet with real potential.

If you wanted to play short-term, CFDs offered the possibility to speculate on these movements without owning the stocks. Leverage could amplify gains, but also losses, so caution was necessary. The volatility from geopolitical events or central bank decisions created opportunities for those who knew how to move quickly.

But if your horizon was longer, the strategy was different. You needed to focus on companies with solid fundamentals, diversify well across sectors, and not get scared by short-term fluctuations. Spreading investments across several stocks instead of betting everything on one was the sensible approach.

What was clear from that analysis was that 2024 looked set to be a crucial year. Between expectations of rate adjustments, the AI boom, and these five options covering different sectors, there was material to build a balanced portfolio. The key was to choose a regulated broker, do your own research, and establish a clear strategy before entering. The market always rewards those with patience and discipline.